Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Europe Sun.
Press releases published on April 28, 2025
ONWARD Medical Announces Release of 2024 Annual Report
GlobeNewswire
·
April 28, 2025
EINDHOVEN, the Netherlands, April 28, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal …
FreeMove Alliance und „du“ arbeiten zusammen, um multinationalen Unternehmen in den Vereinigten Arabischen Emiraten einen besseren Service zu bieten
GlobeNewswire
·
April 28, 2025
AMSTERDAM und DUBAI, Vereinigte Arabische Emirate, April 28, 2025 (GLOBE NEWSWIRE) -- FreeMove Alliance, die globale Allianz für mobile Telekommunikation zwischen Deutsche Telekom, Orange, Telia und TIM, und du, ein führender Anbieter von Festnetz-, …
FreeMove Alliance and du cooperate to better serve Multinationals in the United Arab Emirates
GlobeNewswire
·
April 28, 2025
AMSTERDAM and DUBAI, United Arab Emirates, April 28, 2025 (GLOBE NEWSWIRE) -- FreeMove Alliance, the global mobile telecommunications alliance between Deutsche Telekom, Orange, Telia, and TIM, and du, a leading provider of fixed, mobile, and digital …
FreeMove Alliance y du cooperan para prestar un mejor servicio a las multinacionales en los Emiratos Árabes Unidos
GlobeNewswire
·
April 28, 2025
ÁMSTERDAM y DUBÁI, Emiratos Árabes Unidos, April 28, 2025 (GLOBE NEWSWIRE) -- FreeMove Alliance, la alianza mundial de telecomunicaciones móviles entre Deutsche Telekom, Orange, Telia y TIM, y du, proveedor líder de servicios de telefonía fija, móvil y …
Purespring Therapeutics granted European Medicines Agency (EMA) orphan drug designation for PS-002 for the treatment of patients with primary IgA nephropathy (IgAN)
GlobeNewswire
·
April 28, 2025
EMA designation provides orphan status to medicines being developed for rare conditions that are intended for the diagnosis, prevention or treatment of diseases affecting fewer than 5 in 10,000 people in the European Union Purespring has previously …
LIfT BioSciences announces partnership with University of Galway for clinical trial in Ireland
GlobeNewswire
·
April 28, 2025
LIfT BioSciences announces partnership with University of Galway for clinical trial in Ireland London, 28 April 2025– LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech and the global leader in neutrophil immunotherapies, today …
Lʼalliance FreeMove et Du coopèrent pour mieux satisfaire les besoins des multinationales aux Émirats arabes unis
GlobeNewswire
·
April 28, 2025
AMSTERDAM et DUBAI, Émirats arabes unis, 28 avr. 2025 (GLOBE NEWSWIRE) -- L’alliance FreeMove, la plus grande union internationale en matière de télécommunications mobiles conclue entre Deutsche Telekom, Orange, Telia et TIM, et Du, le plus grand …
Vallourec Awarded a Major Contract by Kuwait Oil Company
GlobeNewswire
·
April 28, 2025
Press release VALLOUREC AWARDED A MAJOR CONTRACT BY KUWAIT OIL COMPANY Meudon (France), April 28, 2025 – Vallourec, a world leader in premium seamless tubular solutions, has secured a major contract to supply Oil Country Tubular Goods (OCTG) for the …
VALLOUREC SIGNE UN CONTRAT MAJEUR AVEC KUWAIT OIL COMPANY
GlobeNewswire
·
April 28, 2025
Communiqué de presse VALLOUREC SIGNE UN CONTRAT MAJEUR AVEC KUWAIT OIL COMPANY Meudon (France), le 28 avril 2025 – Vallourec, un leader mondial des solutions tubulaires premium sans soudure, a remporté un contrat majeur pour la fourniture de tubes OCTG …
argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
GlobeNewswire
·
April 28, 2025
VYVGART® is first-and-only targeted IgG Fc-antibody fragment for CIDP First novel mechanism of action for CIDP treatment in more than 30 years CHMP positive opinion based on ADHERE data, the largest ever CIDP clinical trial European Commission (EC) …
BioVersys to Host Virtual KOL Event to Discuss BV100 Phase 2 Ventilator Associated Pneumonia (VABP) Study Against Carbapenem Resistant Acinetobacter on May 7, 2025
GlobeNewswire
·
April 28, 2025
Event titled “BV100 Shows Survival Benefit in Phase 2 Ventilator Associated Pneumonia (VABP) Study Against Carbapenem Resistant Acinetobacter. What Does that Mean for Patients? A Perspective from the US and from Asia” Featuring Professor David Paterson and …